Davis, Emily. “Efficacy of Targeted MRNA Therapeutics in Refractory Autoimmune Disorders: A Phase II Clinical Trial”. Medicine Insights, vol. 2, no. 4, Nov. 2025, pp. 36-47, https://doi.org/10.70088/ba518d61.